Related Experiment Video
Updated: Jun 6, 2026

A Murine Model of Hyperlipidemia-Induced Heart Failure with Preserved Ejection Fraction
Published on: March 29, 2024
Popeye domain-containing 1 is down-regulated in failing human hearts
Rachel Gingold-Belfer1, Michael Bergman, Yifat Alcalay
1Basil and Gerald Felsenstein Medical Research Center, Sackler Faculty of Medicine, Tel-Aviv University, Petach-Tikva 49100, Israel.
Insights
Congestive heart failure alters Popeye domain-containing (POPDC) gene expression in human hearts. POPDC1 levels decrease, particularly in the left ventricle, suggesting its susceptibility to heart failure.
Area of Science:
- Cardiovascular Biology
- Molecular Genetics
- Gene Expression Regulation
Background:
- Congestive heart failure (CHF) involves complex genetic alterations.
- The Popeye domain-containing (POPDC) gene family (POPDC1-3) is muscle-restricted and developmentally regulated.
- POPDC1's role in stressed mouse muscle is known, but its function in human hearts is unexplored.
Purpose of the Study:
- To investigate the cellular distribution and expression of POPDC1 in human hearts.
- To analyze the expression patterns of POPDC1-3 mRNAs in non-failing and failing human hearts.
- To determine the impact of heart failure on POPDC gene expression.
Main Methods:
- Immunohistochemistry and Western immunoblotting for POPDC1 protein.
- Reverse transcription/quantitative polymerase chain reaction for POPDC1-3 and MYHC7 mRNA levels.
- Analysis of human heart biopsies from non-failing and failing individuals.
Main Results:
- POPDC1 localized to the sarcolemma, enhanced at intercalated discs, with deranged labeling in failing hearts.
- All three POPDC mRNAs expressed in all four chambers, higher in ventricles.
- Heart failure correlated with reduced POPDC1 mRNA and protein in the left ventricle.
- Coordinated regulation observed between POPDC1/POPDC3 and POPDC2/MYHC7 mRNA levels.
Conclusions:
- POPDC gene expression is significantly modified in end-stage human heart failure.
- Evidence suggests differential regulation and function among POPDC family members.
- POPDC1 appears particularly susceptible to the pathological changes in heart failure.
Abstract:
Congestive heart failure, a complex disease of heterogeneous etiology, involves alterations in the expression of multiple genes. The Popeye domain-containing (POPDC) family of three novel muscle-restricted genes (POPDC1-3) is evolutionarily conserved and developmentally regulated. In mice, POPDC1 has been shown to play an important role in skeletal and cardiac muscles subjected to injury or stress. However, it has never been explored in human hearts. In biopsies from non-failing and failing human hearts, we examined the cellular distribution of POPDC1 as well as the expression patterns of POPDC1-3 mRNAs. POPDC1 was visualized by immunohistochemistry and estimated by Western immunoblotting. The mRNA levels of POPDC1-3 and ß myosin heavy chain (MYHC7) were assessed using reverse transcription/quantitative polymerase chain reaction. POPDC1 was predominantly localized in the sarcolemma with an enhanced expression in the intercalated discs. In failing hearts, many cardiomyocytes appeared deformed and POPDC1 labeling was deranged. The three POPDC mRNAs were expressed in the four heart chambers with higher transcript levels in the ventricles compared to the atria. Heart failure concurred with reduced levels of POPDC1 mRNA and protein in the left ventricle. Correlation analyses of mRNA levels among the failing heart specimens indicated the coordinated regulation of POPDC1 with POPDC3 and of POPDC2 with MYHC7. It can be concluded that POPDC gene expression is modified in end-stage heart failure in humans in a manner suggesting regulatory and/or functional differences between the three family members and that POPDC1 is particularly susceptible to this condition.
Related Concept Videos
Heart Failure II: Pathophysiology
Pathophysiology of Heart Failure
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Coronary Artery Disease II: Pathophysiology
Cardiomyopathy IV: Restrictive Cardiomyopathy
Pathophysiology of Cardiac Performance
